Pfizer Stock Rises as Drug Giant Sees 2025 Revenue of $61 Billion to $64 Billion

The company anticipates adjusted earnings of between $2.80 and $3 a share in 2025. Analysts had been expecting adjusted earnings of $2.86.

OK